USPatent applicationPatented

1,2,3-Thiadiazole derivatives or salts thereof and agrohorticultural disease controller

Granted 8 Jan 2002 · 1 office action

Application· this page
9665591
filed 19 Sep 2000
Publication
Not published
not published
Patent
US 6,337,341
granted 8 Jan 2002

Life of the application

7 dated events
⤢ drag to zoom20002002200420062008201020122014201620182020ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

A 1,2,3-thiadiazole derivative represented by general formula (I) or a salt thereof: wherein R1 is H, (halo) C1-C4 alkyl, 5- or 6-membered heterocycle containing 1 to 3 same or different O, N or S or the like, A is a group of the following formulas: wherein R2 and R3 are H, halogen, cyano, formyl, alkylthio, alkoxycarbonyl, substituted or unsubstituted phenyl, or the like, or R2 and R3, taken conjointly, may form a 3- to 7-membered ring including a C2-C6 alkylene group which may be intercepted by O, S(O)n (n is 0-2), CO or NR8 (R8 is H, halogen or the like), B is cyano or an unsubstituted or substituted 5- or 6-membered heterocycle containing 1-3 hetero atoms selected from O, N and S, and m is 0-4; salts thereof; an agrohorticultural disease controller containing said derivative or salt; and method for using said disease controller.

Description

29 parts
›This is a continuation of application Ser. No…

This is a continuation of application Ser. No. 09/276,705, filed Mar. 26, 1999 which is a continuation of PCT/JP97/03467 filed Sep. 29, 1997.

›TECHNICAL FIELD

The present invention relates to 1,2,3-thiadiazole derivatives and salts thereof, and agrohorticultural disease controller containing said compound as an active ingredient, and method for using the disease controller.

›BACKGROUND ART

1,2,3-Thiadiazoles are disclosed in JP-A-2-149579/1990 as an agent for treating central nervous system diseases, in JP-A-54-9272/1979, JP-A-3-181463/1991, JA-A-4-234881/1992, Canadian Patent 947297, etc. as a herbicide or a plant growth regulator, and in WO 9501340 and JP-A-7-252242/1995 as a fungicide.

›DISCLOSURE OF THE INVENTION · 1 of 3

With the aim of creating a novel agrohorticultural disease controller, the present inventors have conducted extensive studies to find that the 1,2,3-thiadiazole derivatives of the present invention represented by general formula (I) or salts thereof which are novel compounds not found in literature are useful as an agrohorticultural disease controller. Based on this finding, the present invention has been accomplished.

The present invention relates to 1,2,3-thiadiazole derivatives represented by the following general formula (I) or salts thereof, an agrohorticultural disease controller containing said compounds as an active ingredient, and a method for using said disease controller:

wherein R 1 represents hydrogen atom, C 1 -C 8 alkyl group, halo C 1 -C 4 alkyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, halo C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, 5- or 6-membered heterocycle containing 1 to 3 same or different heteroatoms selected from oxygen atom, nitrogen atom and sulfur atom, or substituted 5- or 6-membered heterocycle containing 1 to 3 same or different heteroatoms selected from oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups;

A represents a group of the following formula:

(wherein R 2 and R 3 , same or different, represent hydrogen atom, halogen atom, cyano group, formyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, C 1 -C 4 alkylsulfinyl group, C 1 -C 4 alkylsulfonyl group, C 1 -C 4 alkylcarbonyl group, C 1 -C 4 alkoxycarbonyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, halo C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, phenylcarbonyl group, or substituted phenylcarbonyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, C 1 -C 4 alkyl group and C 1 -C 4 alkoxycarbonyl group; further, R 2 and R 3 may be taken conjointly to form a 3- to 7-membered ring including a C 2 -C 6 alkylene group which may be intercepted by

—O—,

—S(O) n — in which n is an integer of 0 to 2,

—CO— or

—NR 8 — in which R 8 represents hydrogen atom,

formyl group, C 1 -C 8 alkyl group, halo C 1 -C 4 alkyl group, C 2 -C 4 alkenyl group, halo C 2 -C 4 alkenyl group, C 2 -C 4 alkynyl group, halo C 2 -C 4 alkynyl group, C 1 -C 4 alkylthio group, C 1 -C 4 alkylsulfinyl group, C 1 -C 4 alkylsulfonyl group, C 1 -C 4 alkylcarbonyl group, C 1 -C 4 alkoxycarbonyl group, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl group and phenyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, phenyl C 1 -C 4 alkyl group, substituted phenyl C 1 -C 4 alkyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, phenylcarbonyl group, or substituted phenylcarbonyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group; and said 3- to 7-membered ring may be substituted by one or more same or different substituents selected from the group consisting of halogen atom and C 1 -C 4 alkyl group; and m represents an integer of 0 to 4), or

in which R 2 and R 3 are as defined above, or

in which R 2 and R 3 are as defined above, or

in which R 2 and R 3 are as defined above; and

in the case that m is 0 in the definition of A, B represents cyano group, 5- or 6-membered heterocycle having 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 14 C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different C 1 -C 4 alkyl or phenyl groups, carbamoyl group, substituted carbamoyl group having 1 or 2 C 1 -C 4 alkyl or phenyl groups, carbamoyl C 1 -C 4 alkyl group and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different C 1 -C 4 alkyl or phenyl groups, or

›DISCLOSURE OF THE INVENTION · 2 of 3

—C(═X) R 4

(in which R 4 represents hydrogen atom, C 1 -C 8 alkyl group, halo C 1 -C 4 alkyl group, C 2 -C 4 alkenyl group, halo C 2 -C 4 alkenyl group, C 2 -C 4 alkynyl group, halo C 2 -C 4 alkynyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, phenyl C 1 -C 4 alkyl group, substituted phenyl C 1 -C 4 alkyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, or substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl group and phenyl group, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl group and phenyl group, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl group and phenyl group, and

X represents O, S,

N—R 6 in which R 6 is as defined later,

NO—R 6 in which R 6 is as defined later,

N(→O)—R 6 in which R 6 is as defined later,

NN(R 6 )R 7 in which R 6 and R 7 are as defined later, or

NN═C(R 6 )R 7 (in which R 6 and R 7 , same or different, represent hydrogen atom, halogen atom, formyl group, C 1 -C 4 alkyl group, C 2 -C 4 alkenyl group, C 2 -C 4 alkynyl group, C 1 -C 4 alkylsulfonyl group, halo C 1 -C 4 alkylsulfonyl group, C 1 -C 20 alkylcarbonyl group, C 1 -C 4 alkoxycarbonyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, halo C 1 -C 4 alkoxy group, amino group and C 1 -C 4 alkoxycarbonyl group, phenyl C 1 -C 4 alkyl group, substituted phenyl C 1 -C 4 alkyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, halo C 1 -C 4 alkoxy group, amino group and C 1 -C 4 alkoxycarbonyl group, phenylcarbonyl group, substituted phenylcarbonyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, halo C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl group, phenyl group and substituted phenyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, C 1 -C 4 alkyl group, halo C 1 -C 4 alkyl group, C 1 C 4 alkoxy group and halo C 1 -C 4 alkoxy group, phenylsulfonyl group, substituted phenylsulfonyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, nitro group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, thiocarbamoyl group, substituted thiocarbamoyl group substituted by same or different C 1 -C 4 alkyl or phenyl group, C 1 -C 4 alkoxy carbonimidoyl group, substituted C 1 -C 4 alkoxy carbonimidoyl group having, on the nitrogen atom thereof, same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, C 1 -C 4 alkylthio carbonimidoyl group, substituted C 1 -C 4 alkylthio carbonimidoyl group having, on the nitrogen atom thereof, same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, C 1 -C 4 alkylsulfinyl carbonimidoyl group, substituted C 1 -C 4 alkylsulfinyl carbonimidoyl group having, on the nitrogen atom thereof, same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, C 1 -C 4 alkylsulfonyl carbonamidoyl group, substituted C 1 -C 4 alkylsulfonyl carbonamidoyl group having, on the nitrogen atom thereof, same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, amidino group, substituted amidino group having same or different substituents selected from the group consisting of C 1 -C 6 alkyl and phenyl groups, 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, or substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups; and R 6 and R 7 may be taken conjointly to form a 3- to 7-membered ring including a C 2 -C 6 alkylene group which may be intercepted by

›DISCLOSURE OF THE INVENTION · 3 of 3

—O—,

—S(O) n — in which n is as defined above,

—CO—, or

—NR 8 — in which R 8 is as defined above,

and said 3- to 7-membered ring may have same or different substituents selected from the group consisting of halogen atom and C 1 -C 4 alkyl group)); and

in cases where m is 1 or greater, B represents hydrogen atom, halogen atom, cyano group, 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 3 same or different substituents selected from the group consisting of halogen atom, hydroxyl group, cyano group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups,

—C(═X)R 5

(in which X is as defined above; and R 5 represents hydrogen atom, C 1 -C 8 alkyl group, halo C 1 -C 4 alkyl group, C 2 -C 4 alkenyl group, halo C 2 -C 4 alkenyl group, C 2 -C 4 alkynyl group, halo C 2 -C 4 alkynyl group, phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, phenyl C 1 -C 4 alkyl group, substituted phenyl C 1 -C 4 alkyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, 5- to 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups,

O—R 6 in which R 6 is as defined above,

S(O) n —R 6 in which n and R 6 are as defined above, or

N(R 6 )R 7 in which R 6 and R 7 are as defined above),

(wherein R 5 is as defined above; and R 9 and R 10 , same or different, represent formyl group, C 1 -C 4 alkylcarbonyl group, C 1 -C 4 alkoxycarbonyl group, phenylcarbonyl group, or substituted phenylcarbonyl group having, on the ring thereof, 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group; further, R 9 and R 10 may be taken conjointly to form a 3- to 7-membered ring including a C 2 to C 6 alkylene group which may be intercepted by

—O—,

—S(O) n — in which n is as defined above,

—CO—, or

—N(R 8 )— in which R 8 is as defined above, and said 3- to 7-membered ring may have one or more same or different substituents selected from the group consisting of halogen atom and C 1 -C 4 alkyl group),

O—R 6 in which R 6 is as defined above,

S(O) n —R 6 in which R 6 and n are as defined above,

N(R 6 )R 7 in which R 6 and R 7 are as defined above,

N═C(R 6 )R 7 in which R 6 and R 7 are as defined above, or

ON═C(R 6 )R 7 in which R 6 and R 7 are as defined above.

›BEST MODE FOR CARRYING OUT THE INVENTION · 1 of 4

In the definitions of the substituents in the 1,2,3-thiadiazole derivatives of the present invention represented by general formula (I), the term “halogen atom” means chlorine atom, bromine atom, iodine atom or fluorine atom; the term “C 1 -C 8 alkyl group” means a straight or branched chain alkyl group having 1 to 8 carbon atoms such as methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl and the like; the term “halo C 1 -C 4 alkyl group” means a straight or branched chain alkyl group having 1 to 4 carbon atoms and substituted by one or more same or different halogen atoms, the term “C 2 -C 4 alkenyl group” means a straight or branched chain alkenyl group having 2 to 4 carbon atoms and a double bond, and the term “halo C 2 -C 4 alkenyl group” means a straight or branched chain alkenyl group having 2 to 4 carbon atoms and substituted by at least one same or different halogen atom.

The term “C 2 -C 4 alkynyl group” means a straight or branched chain alkynyl group having 2 to 4 carbon atoms and a triple bond, the term “halo C 2 -C 4 alkynyl group” means a straight or branched chain alkynyl group having 2 to 4 carbon atoms and substituted by one or more same or different halogen atoms, and the term “5- or 6-membered heterocycle containing at least one same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom” means a 5- or 6-membered ring such as furan, thiophene, pyrrole, oxazole, thiazole, isothiazole, pyrazole, imidazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,2,4-triazole, pyridine, pyridazine, pyrimidine, pyrazine, pyrrolidine, piperidine, morpholine, thiomorpholine, dithiolane, dithiane, piperazine, dioxolane, imidazolidine and the like.

As examples of the salt of 1,2,3-thiadiazole derivative represented by general formula (I), there can be referred to salts of alkali metals such as sodium, potassium and the like, salts of alkaline earth metals such as calcium, magnesium and the like, ammonium salts, substituted ammonium salts substituted by one or more same or different substituents selected from the group consisting of C 1 -C 12 alkyl group, phenyl group, substituted phenyl group, benzyl group or substituted benzyl group, guanidium salt and the like.

As preferred substituents of the present invention, the following are referred to. Thus, as R 1 , methyl, ethyl, n-propyl, cyclopropyl and the like are preferred. As A, a single bond (B is directly linked to thiadiazole ring) or methylene are preferred. In a case where A is a single bond, B is preferably cyano, formyl, hydroxyiminomethyl, benzyloxyiminomethyl, hydrazonomethyl, phenylhydrazonomethyl, imidazolin-2-yl, 4-methylthiazol-2-yl and the like. In a case where A is methylene, B is preferably chlorine atom, hydroxyl group, methoxy group, benzyloxy group, acetoxy group, benzoyloxy group, ethoxycarbonyloxy group, amino group and hydrochloride thereof, diethylamino group, dipropenylamino group, benzoylamino group, p-toluenesulfonylamino group, 3-phenylureido group, 4-methyl-1,2,3-thiadiazol-5-ylmethoxy group and the like.

The 1,2,3-thiadiazole derivatives of the present invention represented by general formula (I) and salts thereof can be produced, for example, by the Production processes exemplified below.

wherein R 1 is as defined above and R 11 represents C 1 -C 8 alkyl group.

A 1,2,3-thiadiazole derivative represented by general formula (I-1) can be produced by reducing a compound of general formula (II) in the presence of a reductant to form a 1,2,3-thiadiazole derivative represented by general formula (I-1) and, after isolating or without isolating the thus formed (I-1), oxidizing (I-1) in the presence of an oxidant.

This reaction can be performed according to the description of Shin Jikken Kagaku Koza, Vol. 15 (II), p. 191 (Maruzen K. K.); Jikken Kagaku Koza (4th edition), Vol. 23(V), p. 43 (Maruzen K. K.), etc.

wherein R 1 and R 11 are as defined above, and R 4′ represents phenyl group, substituted phenyl group having 1 to 5 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group and C 1 -C 4 alkoxycarbonyl group, 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom, or substituted 5- or 6-membered heterocycle containing 1 to 3 same or different hetero atoms selected from the group consisting of oxygen atom, nitrogen atom and sulfur atom and having 1 to 4 same or different substituents selected from the group consisting of halogen atom, cyano group, hydroxyl group, mercapto group, C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, C 1 -C 4 alkylthio group, carbonyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, amino group, substituted amino group having 1 or 2 same or different substituents selected from the group consisting C 1 -C 4 alkyl and phenyl groups, carbamoyl group, substituted carbamoyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups.

A 1,2,3-thiadiazole derivative represented by general formula (I-3) can be produced by hydrolyzing a compound of general formula (II) and then reacting it with thionyl chloride to form a compound represented by general formula (III), and after isolating compound (III) or without isolating (III), reacting (III) with a compound of general formula (IV) in the presence of a catalyst.

This reaction can be performed according to the description of “Shin Jikken Kagaku Koza”, Vol. 14(II), p. 794.

wherein R 1 , R 4 and R 6 are as defined above.

›BEST MODE FOR CARRYING OUT THE INVENTION · 2 of 4

A 1,2,3-thiadiazole derivative represented by general formula (I-5) can be produced by reacting a 1,2,3-thiadiazole derivative of general formula (I-4) with a compound represented by general formula (V).

This reaction can be performed according to the description of “Jikken Kagaku Koza” (4th edition), Vol. 20 (V), p. 353.

wherein R 1 , R 4 , R 6 and R 7 are as defined above.

A 1,2,3-thiadiazole derivative represented by general formula (I-6) can be produced by reacting a 1,2,3-thiadiazole derivative of general formula (I-4) with a compound represented by general formula (VI).

This reaction can be performed according to the description of Org. Synth. Coll. VI, p.12 (1988).

wherein R 1 and R 6 are as defined above and Hal represents halogen atom.

A 1,2,3-thiadiazole derivative represented by general formula (I-8) or (I-9) can be produced by treating a 1,2,3-thiadiazole derivative represented by general formula (I-1) with a halogenating agent such as thionyl chloride or phosphorus tribromide to form a compound represented by general formula (III′), and after isolating the compound (III′) or without isolating (III′), reacting the compound (III′) with sodium formimide and then with an acid such as hydrochloric acid to form a salt of a 1,2,3-thiadiazole derivative represented by general formula (I-7), and then reacting the salt (I-7) with a compound of formula (VII). Further, if a salt of the 1,2,3-thiadiazole derivative of formula (I-7) is reacted with an isocyanate of formula (VIII), a 1,2,3-thiadiazole derivative of general formula (I-8′) can be obtained.

This reaction can be performed according to the description of “Jikken Kagaku Koza” (4th edition), Vol. 19 (I), p. 438; Synthesis, 615 (1990); “Jikken Kagaku Koza” (4th edition), Vol. 22 (II), p. 1142; “Shin Jikken Kagaku Koza”, Vol. 14 (III), p. 1631; etc.

wherein R 1 , R 6 and Hal are as defined above.

A 1,2,3-thiadiazole derivative represented by general formula (I-10) can be produced by reacting a 1,2,3-thiadiazole derivative of formula (I-1) with a compound represented by formula (VII) in the presence of a base.

This reaction can be performed according to the description of “Jikken Kagaku Koza” (4th edition), Vol. 22 (V), p. 50.

wherein R 1 , R 6 and Hal are as defined above and n′ represents an integer of 1-2.

A 1,2,3-thiadiazole derivative represented by general formula (I-12) can be produced by reacting a 1,2,3-thiadiazole derivative of general formula (I-1) with a compound represented by general formula (IX) in the presence of a base to form a 1,2,3-thiadiazole derivative represented by general formula (I-11), and after isolating the compound (I-11) or without isolation it, oxidizing the derivative (I-11) in the presence of an oxidant.

This reaction can be performed according to the description of “Shin Jikken Kagaku Koza”, Vol. 14 (III), p. 1716; “Jikken Kagaku Koza” (4th edition), Vol. 24 (VI), p. 365; etc.

wherein R 1 and Hal are as defined above; and R 2 and R 13 , same or different, represent C 1 -C 4 alkyl group, carboxyl group, carboxy C 1 -C 4 alkyl group, C 1 -C 4 alkoxycarbonyl group, C 1 -C 4 alkoxycarbonyl C 1 -C 4 alkyl group, carbamoyl group, substituted carbamoyl having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups, carbamoyl C 1 -C 4 alkyl group, and substituted carbamoyl C 1 -C 4 alkyl group having 1 or 2 same or different substituents selected from the group consisting of C 1 -C 4 alkyl and phenyl groups.

A 1,2,3-thiadiazole derivative represented by general formula (I-13) can be produced by reacting a compound represented by general formula (X) with phosphorus pentasulfide and then with a compound represented by general formula (XI).

This reaction can be performed according to the description of “Shin Jikken Kagaku Koza”, Vol. 14 (IV), p. 2198; Org. Synth., Coll. Vol. III, p. 332 (1955); etc.

wherein R 1 is as defined above, R 14 represents hydrogen atom or C 1 -C 4 alkyl, and W represents C 3 -C 6 alkylene group which may be substituted by C 1 -C 4 alkyl group and may be intercepted by

—O—,

—NR 6 — in which R 6 is as defined above,

—S(O) n — in which n is as defined above, or

—CO—.

A 1,2,3-thiadiazole derivative represented by general formula (I-15) can be produced by subjecting a compound of general formula (X) to a dehydrating reaction to form a 1,2,3-thiadiazole derivative represented by general formula (I-14), and after isolating the derivative (I-14) or without isolating it, reacting the derivative (I-14) with a compound represented by general formula (XII).

This reaction can be performed according to the description of “Shin Jikken Kagaku Koza”, Vol. 14 (II), p. 1190.

wherein R 1 , R 2 , R 3 and B are as defined above.

A 1,2,3-thiadiazole derivative represented by general formula (I-17) can be produced by reacting a 1,2,3-thiadiazole derivative represented by general formula (I-16) with a compound represented by formula (XIII) or formula (XIV).

This reaction can be performed according to the description of “Shin Jikken Kagaku Koza”, Vol. 14 (I), p. 224; JP-A-7-165757/1995; etc.

The compound of general formula (II) used as a starting compound for production of the 1,2,3-thiadiazine derivative represented by general formula (I) can be produced, for example, by the following method.

wherein R 1 is as defined above, R 11 represents C 1 -C 8 alkyl group, and R 12 represents C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group or amino group which may have a substituent.

A compound represented by general formula (II) can be produced by reacting a compound represented by general formula (XV) with a compound represented by general formula (XVI) to form a compound represented by general formula (XVII), and after isolating the compound (XVII) or without isolating it, subjecting the compound (XVII) to ring closure using thionyl chloride.

This reaction can be preformed according to the description of J. Am. Chem. Soc., 77, 5359 (1955), etc.

Next, typical examples of the 1,2,3-thiadiazole derivative of the present invention represented by general formula (I) are mentioned below. The invention is by no means limited by these examples.

›BEST MODE FOR CARRYING OUT THE INVENTION · 3 of 4

In Table 1, meaning of the abbreviations are as follows.

Ph: phenyl group

cyclo: alicyclic hydrocarbon

In some of the compounds shown in Table 1, property is expressed by a term of “Paste”. Table 2 summarizes the data concerning these compounds.

The 1,2,3-thiadiazole derivatives of the general formula (I) or salts thereof according to the present invention are useful for agricultural and horticultural disease control. For example, these compounds have a very high controlling effect against various diseases, for instance, rice blast ( Pyricularia oryzae ), rice sheath blight ( Rhizoctonia solani ), rice helminthosporium leaf spot ( Cochiobolus miyabeanus ), powdery mildew of various host plants such as powdery mildew of barley and wheat ( Erysiphe graminis ), oats crown rust ( Puccinia coronata ) and rust of other plants, tomato late blight ( Phytophthora infestans ) and late blight or Phytophthora rots of other plants, downy mildew of various plants such as cucumber downy mildew ( Pseudoperonospora cubensis ) and grape downy mildew ( Plasmopara viticola ), apple scab ( Venturia inaequalis ), apple alternaria leaf spot ( Alternaria mali ), pear black spot ( Alternaria kikuchiana ), citrus melanose ( Diaporthe citri ), bacterial diseases including Pseudomonas diseases such as cucumber bacterial blight ( Pseudomonas syringae pv. lachrymans ) and tomato bacterial wilt ( Pseudomonas solanacearum ), Xanthomonas diseases such as cabbage black rot ( Xanthomonas campestris ), rice bacterial leaf blight ( Xanthomonas oryzae ) and citrus canker ( Xanthomonas citri ) and Erwinia diseases such as cabbage bacterial soft rot ( Erwinia carotovora ), and viral diseases such as tobacco mosaic ( Tobacco mosaic virus).

The agrohorticultural disease controller containing the 1,2,3-thiadiazole derivative of general formula (I) or salts thereof as an active ingredient according to the present invention exhibits a marked controlling effect against the above-exemplified diseases which damage paddy field crops, upland field crops, fruit trees, vegetables, other crop plants, flowers, ornamental plants, and the like. Accordingly, the desired effects of the agrohorticultural disease controller of the present invention can be exhibited by applying the disease controller to the paddy field water, stalks and leaves or soil of the paddy field, upland field, fruit trees, vegetables, other crops, flowers and ornamental plants at a season at which the diseases are expected to occur, either before their occurrence or at the time when their occurrence has been confirmed.

The agrohorticultural disease controller of the present invention is generally put to use after being prepared into a conveniently usable form according to an ordinary manner for preparation of pesticides.

That is, the 1,2,3-thiadiazole derivative represented by the general formula (I) or a salt thereof according to the present invention and, optionally, an adjuvant are blended with an appropriate inert carrier in a proper proportion and dissolved, separated, suspended, mixed, impregnated, adsorbed or stuck, prepared into a suitable preparation form such as suspension, emulsifiable concentrate, soluble concentrate, wettable powder, granule, dust, tablet, etc. and put to use.

The inert carrier used in the present invention may be either solid or liquid. As the material usable as solid carrier, there can be exemplified soybean flour, cereal flour, wood flour, bark flour, saw dust, powdered tobacco stalks, powdered walnut shells, bran, powdered cellulose, extraction residue of vegetables, powdered synthetic polymers of synthetic resins and the like, clays such as kaolin, bentonite, acid clay and the like, talcs such as talc, pyrophyllite and the like, silica materials such as diatomaceous earth, siliceous sand, mica, white carbon (namely, synthetic, high-dispersion silicic acid , also called finely divided hydrated silica or hydrated silicic acid, some of the commercially available products thereof contain calcium silicate as the major component), activated carbon, powdered sulfur, pumice, calcined diatomaceous earth, crushed brick, fly ash, sand, inorganic mineral powders such as calcium carbonate, calcium phosphate and the like, chemical fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride and the like, and compost. These carriers may be used alone or as a mixture thereof.

The material constituting the liquid carrier is selected from materials having a dissolving ability in themselves and materials which have no dissolving ability in themselves but can disperse the active ingredient compound by the aid of an adjuvant. The following are typical examples of the liquid carrier material, which can be used either alone or in the form of a mixture: water; alcohols such as methanol, ethanol, isopropanol, butanol, ethylene glycol and the like; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, diisobutyl ketone, cyclohexanone and the like; ethers such as ethyl ether, dioxane, cellosolve, dipropyl ether, tetrahydrofuran and the like; aliphatic hydrocarbons such as kerosene, mineral oils and the like; aromatic hydrocarbons such as benzene, toluene, xylene, solvent naphtha, alkyl-naphthalene and the like; halogenated hydrocarbons such as dichloroethene, chloroform, carbon tetrachloride, chlorobenzene and the like; esters such as ethyl acetate, diisopropyl phthalate, dibutyl phthalate, dioctyl phthalate and the like; amides such as dimethylformamide, diethylformamide, dimethylacetamide and the like; nitrites such as acetonitrile and the like; dimethyl sulfoxide; etc.

As the adjuvant, the following can be referred to as typical ones. These adjuvants are used depending upon purposes, either alone or in combination of two or more in some cases. It is also possible to use no adjuvant at all, in some cases.

A surfactant is used for the purpose of emulsifying, dispersing, solubilizing and/or wetting an active ingredient compound. As the surfactant, there can be exemplified polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyoxyethylene higher fatty acid esters, polyoxyethylene resin acid esters, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monooleate, alkylarylsulfonates, naphthalenesulfonic acid condensates, ligninsulfonic acid salts, higher alcohol sulfuric esters, etc.

›BEST MODE FOR CARRYING OUT THE INVENTION · 4 of 4

The following adjuvants can also be used for the purpose of stabilizing, tackifying and/or binding the dispersion of active ingredient compound: casein, gelatin, starch, methyl cellulose, carboxymethyl cellulose, gum arabic, polyvinyl alcohol, turpentine, bran oil, bentonite, ligninsulfonic acid salts and the like.

Further, wax, stearic acid salts, alkyl phosphates and the like may be used as an adjuvant for the purpose of improving flowability of a solid product.

Further, naphthalenesulfonic acid condensates, polycondensed phosphoric acid salts and the like may also be used as a peptizer for dispersible products.

Adjuvants such as silicone oils may also be used as a defoaming agent.

The content of the active ingredient compound may be increased or decreased according to the need. For example, in dusts and granules, the suitable content thereof is from 0.01 to 50% by weight. In emulsifiable concentrates and wettable powders, too, the suitable content thereof is from 0.01 to 50% by weight.

For controlling various diseases, the agrohorticultural disease controller of the present invention itself or its appropriate dilution or suspension in water or the like is applied to a crop on which the diseases are expected to occur or a site where occurrence of the diseases is undesirable, in an amount effective for disease control. For example, for controlling the diseases of paddy rice, said disease controller can be used by a method such as direct application to regular paddy field, application to a rice nursery bed, dressing of seeds for direct sowing to flooded paddy field, seed disinfection, etc. For controlling the diseases of barley, wheat, oat or the like, the disease controller of the present invention is applied to stalks and leaves or used for soil treatment where the disease controller is absorbed from the roots.

The application amount of the agrohorticultural disease controller of the present invention may vary depending on various factors including purpose of application, objective disease, state of plant growth, tendency of prevalence of the disease, weather, environmental conditions, preparation form, method of application, site of application, time of application, etc. The application amount, however, should be properly chosen in the range of from 0.1 g to 10 kg per 10 ares as expressed in terms of amount of active ingredient compound, depending on purposes.

In order to expand the spectrum of controllable diseases and the time period of effective application or to reduce the dosage, it is also possible to use the disease controller of the present invention in the form of a mixture with other agrohorticultural disease controllers.

Next, typical examples, formulation examples and test examples of the 1,2,3-thiadiazole derivatives of general formula (I) or salts thereof according to the present invention are presented below. The present invention is by no means limited by these examples.

›Examples19
›EXAMPLE 1

Production of 4-methyl-1,2,3-thiadiazole-5-carbaldehyde (Compound No. 7)

In 25 ml of methylene chloride were suspended 9.9 g (46 mmol) of pyridinium chlorochromate and 10 g of silica gel. After adding 3.0 g (23 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol, the mixture was stirred at room temperature for 4 hours to make a reaction progress. After the reaction was completed, the reaction mixture was diluted with ether, the resulting florisil was filtered off, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 2.0 g of the objective compound was obtained.

Property: nD 1.5555 (26° C.)

Yield: 62%

›EXAMPLE 2

Production of 5-benzoyl-4-methyl-1,2,3-thiadiazole (Compound No. 9)

To 2.0 g (15 mmol) of thionyl chloride was added 0.50 g (3.5 mmol) of 4-methyl-1,2,3-thiadiazole-5-carboxylic acid. After heating the mixture with stirring for 2 hours, the thionyl chloride was distilled off under reduced pressure, and the residue was added to a solution of 1.8 g (15 mmol) of aluminum chloride in 20 ml benzene and made to react with heating for 3 hours. After the reaction was completed, the reaction mixture was poured into ice water, the objective product was extracted with ethyl acetate, the organic layer was washed with a saturated aqueous solution of sodium chloride and dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 4:1 mixture of n-hexane and ethyl acetate. Thus, 0.69 g of the objective compound was obtained.

Property: nD 1.6145 (22° C.)

Yield: 97%

›EXAMPLE 3

Production of O-benzyl-4-methyl-1,2,3-thiadiazole-5-carbaldehyde oxime (Compound No. 21)

To 10 ml of ethanol were added 0.40 g (3.1 mmol) of 4-methyl-1,2,3-thiadiazole-5-carbaldehyde obtained in Example 1, 0.60 g (3.8 mmol) of benzyloxyamine hydrochloride and 0.50 g (3.8 mmol) of sodium acetate. The mixture was stirred for 4 hours with heating under reflux. After the reaction was completed, the reaction mixture was diluted with ethyl acetate and filtered to remove the precipitate, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using 4:1 mixture of n-hexane and ethyl acetate. Thus, 0.66 g of the objective compound was obtained.

Property: nD 1.5998 (25° C.)

Yield: 91%

›EXAMPLE 4

Production of 5-(5-mercapto-1,3,4-oxadiazol-2-yl)-4-methyl-1,2,3-thiadiazole (Compound No. 102)

A solution of 0.3 g of potassium hydroxide in 1 ml water and 0.6 ml of carbon disulfide were successively added to a solution of 1.1 g (7.2 mmol) of 4-methyl-1,2,3-thiadiazole-5-carbohydrazide in 15 ml ethanol. The mixture was stirred for 6.5 hours with heating under reflux. After the reaction was completed, the solvent was distilled off under reduced pressure, water was added to the residue, acetic acid was added for the sake of acidification, and the deposited crystalline product was collected by filtration. Thus, 0.82 g of the objective compound was obtained.

Property: m.p. 182° C.

Yield: 59%

›EXAMPLE 5

Production of 4-methyl-5-(5-methylthio-1,3,4-oxadiazol-2-yl)-1,2,3-thiadiazole (Compound No. 103)

To 10 ml of acetone were added 0.40 g (2.0 mmol) of 5-(5-mercapto-1,3,4-thiadiazol-2-yl)-4-methyl-1,2,3-thiadiazole, 0.43 g (3.0 mmol) of methyl iodide and 0.83 g (6.0 mmol) of potassium carbonate. The mixture was stirred for 5 hours with heating under reflux. After the reaction was completed, the reaction mixture was filtered to remove the insoluble matter, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using 2:1 mixture of n-hexane and ethyl acetate. Thus, 0.41 g of the objective compound was obtained.

Property: m.p. 65° C.

Yield 96%

›EXAMPLE 6

Production of 5-chloromethyl-4-methyl-1,2,3-thiadiazole (Compound No. 104)

While cooling the reaction system with ice, 2 ml of thionyl chloride was added to 0.50 g (3.8 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol. Then, at room temperature, the mixture was stirred for 2 hours. Then, water was added to stop the reaction, the objective product was extracted with ethyl acetate, the organic layer was washed with water and dried, the solvent was distilled off under reduced pressure, and the residue thus obtained was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.46 g of the objective compound was obtained.

Property: nD 1.5590 (26° C.)

Yield: 81%

›EXAMPLE 7

Production of 4-methyl-1,2,3-thiadiazol-5-ylmethanol (Compound No. 105)

To a solution of 0.10 g (2.5 mmol) of sodium hydroxide in 10 ml ethanol was added 1.0 g (5.8 mmol) of ethyl 4-methyl-1,2,3-thiadiazole-5-carboxylate. Then, 0.33 g (8.7 mmol) of sodium borohydride was added and stirred at room temperature. After the reaction was completed, water was added to the reaction mixture to decompose the excessive sodium borohydride, after which the objective product was extracted with ethyl acetate. The organic layer was washed with water and dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 2:1 mixture of n-hexane and ethyl acetate. Thus, 0.36 g of the objective compound was obtained.

Property: nD 1.553 (21° C.)

Yield: 48%

›EXAMPLE 8

Production of 4-methyl-5-benzyloxymethyl-1,2,3-thiadiazole (Compound No. 109)

In 10 ml of acetone was dissolved 0.40 g (3.1 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol. After adding 1.6 g (12 mmol) of potassium carbonate and 0.80 g (4.5 mmol) of benzyl bromide, the resulting mixture was stirred for 10 hours with heating under reflux. After the reaction was completed, the insoluble matter was filtered off, the solvent was distilled off from the filtrate under reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.65 g of the objective compound was obtained.

Property: nD 1.5730 (25° C.)

Yield 96%

›EXAMPLE 9

Production of 4,4′-dimethyl-5,5′-oxybis(methyl-1,2,3-thiadiazole) (Compound No. 129)

In 20 ml of tetrahydrofuran were dissolved 2.0 g (15 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol and 3.9 g (39 mmol) of triethylamine. While cooling the system with ice, 3.5 g (18 mmol) of tosyl chloride was added and stirred at room temperature for 24 hours. Then, a saturated aqueous solution of sodium chloride was added to the reaction mixture to stop the reaction, the objective product was extracted with ethyl acetate, the extract solution was washed successively with dilute hydrochloric acid, a saturated aqueous solution of sodium hydrogen carbonate and a saturated aqueous solution of sodium chloride, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 4:1 mixture of n-hexane and ethyl acetate. Thus, 1.1 g of the objective compound was obtained.

Property: nD 1.547 (26° C.)

Yield: 57%

›EXAMPLE 10

Production of 4-methyl-1,2,3-thiadiazol-5-ylmethyl acetate (Compound No.150)

In 10 ml of tetrahydrofuran were dissolved 0.50 g (3.8 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol, 0.50 g (5.7 mmol) of acetyl chloride and 0.80 g (7.6 mmol) of triethylamine. The solution thus obtained was stirred at room temperature for 18 hours. Then, a saturated aqueous solution of sodium chloride was added to the reaction mixture to stop the reaction, the objective product was extracted with ethyl acetate, the organic layer was washed with water and dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.70 g of the objective compound was obtained.

Property: nD 1.3580 (25° C.)

Yield: 100%

›EXAMPLE 11

Production of ethyl 4-methyl-1,2,3-thiadiazol-5-ylmethyl carbonate (Compound No. 180)

In 5 ml of tetrahydrofuran was dissolved 0.50 g (3.8 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol. After adding 0.80 g (7.6 mmol) of triethylamine and 0.60 g (5.7 mmol) of ethyl chlorocarbonate, the resulting mixture was stirred at room temperature for 22 hours. Then, water was added to the reaction mixture to stop the reaction, the objective product was extracted with ethyl acetate, the organic layer was washed with water and dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 5:1 mixture of n-hexane and ethyl acetate. Thus, 0.50 g of the objective compound was obtained.

Property: nD 1.5041 (26° C.)

Yield: 68%

›EXAMPLE 12

Production of 4-methyl-5-phenylthiomethyl-1,2,3-thiadiazole (Compound No. 209)

At an ice-cooled temperature, 3 ml of thionyl chloride was added to 0.50 g (3.8 mmol) of 4-methyl-1,2,3-thiadiazol-5-ylmethanol and stirred for 4 hours. Then, the reaction mixture was concentrated under reduced pressure, and 1.30 g (11.5 mmol) of potassium carbonate, 0.38 g (3.4 mmol) of thiophenol and 10 ml of acetone were added to the concentrate and reacted for 7 hours with heating under reflux. After the reaction was completed, the reaction mixture was cooled to room temperature, the precipitated matter was filtered off, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 5:1 mixture of n-hexane and ethyl acetate. Thus, 0.64 g of the objective compound was obtained.

Property: nD 1.636 (25° C.)

Yield: 85%

›EXAMPLE 13

Production of 4-methyl-5-phenylsulfonylmethyl-1,2,3-thiadiazole (Compound No. 211)

In 5.0 ml of methylene chloride was dissolved 0.20 g (0.99 mmol) of 4-methyl-5-phenylthiomethyl-1,2,3-thiadiazole. Then, 0.40 g (2.3 mmol) of m-chloroperbenzoic acid was added to the solution obtained above, and was stirred for 20 hours at room temperature. Then, an aqueous solution of sodium hydrogen sulfite was added to the reaction mixture to stop the reaction, the objective product was extracted with ethyl acetate, the organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 2:1 mixture of n-hexane and ethyl acetate. Thus, 0.23 g of the objective compound was obtained.

Property: m.p. 118° C.

Yield: 100%

›EXAMPLE 14

Production of 5-aminomethyl-4-methyl-1,2,3-thiadiazole hydrochloride (Compound No. 220)

To 50 ml of acetonitrile were added 7.0 g (47 mmol) of 5-chloromethyl-4-methyl-1,2,3-thiadiazole and 9.0 g (94 mmol) of sodium formimide. After stirring the resulting mixture for 16 hours with heating under reflux, the reaction mixture was cooled to the room temperature, a saturated aqueous solution of sodium chloride was added, the objective product was extracted with ethyl acetate, the organic layer was washed with water and dried, and the solvent was distilled off under reduced pressure. Then, while stirring the resulting crystalline product together with 40 ml of water, 30 ml of concentrated hydrochloric acid was added. After ten minutes, water and hydrochloric acid were distilled off, and the residue was washed with ethyl acetate. Thus, 6.6 g of the objective compound was obtained.

Property: m.p.>250° C.

Yield: 77%

›EXAMPLE 15

Production of 5-(N,N-diallylamino)methyl-4-methyl-1,2,3-thiadiazole (Compound No. 222)

To 15 ml of acetone were added 0.50 g (3.0 mol) of 5-aminomethyl-4-methyl-1,2,3-thiadiazole ydrochloride, 1.10 g (9.0 mmol) of allyl bromide and 2.1 g (15 mmol) of potassium carbonate. The resulting mixture was stirred for 20 hours with heating under reflux. After the reaction was completed, the reaction mixture was filtered to remove the precipitated matter, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.42 g of the objective compound was obtained.

Property: Pasty product

Yield: 67%

H-NMR [CDCl 3 /TMS, δ value (ppm)] 2.61 (s, 3H), 3.10-3.12 (m, 4H), 3.80 (s, 2H), 5.16-5.24 (m, 4H), 5.78-5.89 (m, 2H)

›EXAMPLE 16

Production of methyl (E)-3-(4-methyl-1,2,3-thiadiazol-5-yl)-2-propenate (Compound No. 338) and methyl (Z)-3-(4-methyl-1,2,3-thiadiazol-5-yl)-2-propenate (Compound No. 341)

To 0.40 g (3.1 mmol) of 4-methyl-1,2,3-thiadiazol-5-carbaldehyde dissolved in tetrahydrofuran was added 1.1 g (3.4 mmol) of methyl triphenylphospholanilideneacetate. The solution thus obtained was stirred for 16 hours at room temperature. After the reaction was completed, the reaction mixture was cooled to room temperature, a saturated aqueous solution of sodium chloride was added, and the objective product was extracted with ethyl acetate. The organic layer was washed with water and dried, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 5:1 mixture of n-hexane and ethyl acetate. Thus, the E-compound and the Z-compound, both the objective compounds, were obtained in yields of 0.49 g and 0.05 g, respectively.

Property:

E-compound m.p. 70° C., Yield 90%

Z-compound m.p. 80-85° C., Yield 10%

›EXAMPLE 17

Production of ethyl 2-cyano-3-(4-methyl-1,2,3-thiadiazol-5-yl)-2-propenate (Compound No. 346)

To 50 ml of toluene were added 1.5 g (12 mmol) of 4-methyl-1,2,3-thiadiazole-5-carbaldehyde, 1.5 g (13 mmol) of ethyl cyanoacetate, 0.40 g (6.0 mmol) of pyrrolidine and 0.20 g (1.2 mmol) of tosylic acid. In a reactor equipped with a Dean-Stark dehydrating apparatus, the mixture obtained above was stirred for 2 hours with heating under reflux. After the reaction was completed, a saturated aqueous solution of sodium chloride was added to the reaction mixture, the objective product was extracted with ethyl acetate, the organic layer was washed successively with dilute hydrochloric acid, saturated aqueous solution of sodium hydrogen carbonate and saturated aqueous solution of sodium chloride, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.73 g of the objective compound was obtained.

Property: Pasty product,

Yield: 30%

H-NMR [CDCl 3 /TMS, δ value (ppm)] 1.41 (t, 3H), 2.90 (s, 3H), 4.20 (q, 2H), 8.34 (s, 1H)

›EXAMPLE 18

Production of 4-phenyl-3,4,5,6-tetrahydropyrimidin-2-yl-1,2,3-thiadiazole (Compound No. 368)

In 10 ml of ethanol were dissolved 0.95 g (5.0 mmol) of 4-phenyl-1,2,3-thiadiazole-5-carbonitrile and 3.8 g (50 mmol) of 1,3-propanediamine. After adding 0.05 g of sodium ethoxide, the solution thus obtained was stirred for 8 hours with heating under reflux. After the reaction was completed, the reaction mixture was cooled to room temperature, the solvent was distilled off under reduced pressure, and the objective product was extracted with ethyl acetate. The organic layer was concentrated under reduced pressure, and the oily product thus obtained was recrystallized from a small quantity of ethyl acetate to obtain 0.68 g of the objective compound.

Property: m.p. 158° C.

Yield: 55%

›EXAMPLE 19

Production of methyl 2-(4-phenyl-1,2,3-thiadiazol-5-yl)thiazole-4-carboxylate (Compound No. 372)

In 20 ml of chlorobenzene were dissolved 1.1 g (5.0 mmol) of 4-phenyl-1,2,3-thiadiazole-5-carbothioamide and 0.92 g (5.0 mmol) of methyl bromopyruvate. The solution thus obtained was stirred for 3 hours with heating under reflux. After the reaction was completed, the reaction mixture was cooled to room temperature, a saturated aqueous solution of sodium hydrogen carbonate was added thereto, and the objective product was extracted with ethyl acetate. The solvent was distilled off from the extract solution under a reduced pressure, and the residue was purified by silica gel column chromatography using 3:1 mixture of n-hexane and ethyl acetate. Thus, 0.74 g of the objective compound was obtained.

Property: m.p. 124° C.

Yield: 41%

Next, typical formulation examples and test examples of the present invention are mentioned below.

In the formulation examples, the term “parts” means “parts by weight”.

Formulation Example 1

The ingredients mentioned above are uniformly mixed and dissolved together to prepare an emulsifiable concentrate.

Formulation Example 2

The ingredients mentioned above are uniformly mixed together and pulverized to prepare a dust.

Formulation Example 3

The ingredient mentioned above are kneaded together with a proper quantity of water, and then granulated and dried to prepare a granular composition.

Formulation Example 4

The ingredients mentioned above are uniformly mixed together and pulverized to prepare a wettable powder.

Test Example 1

Rice Blast-controlling Test by Submerged Application

A chemical agent containing the compound shown in Table 1 as an active ingredient was applied to paddy rice plants of the 5- to 6-leaved stage, cultivated in {fraction (1/10000)} are pots, by the method of submerged application at a dosage of 200 g/10 ares as expressed in terms of active ingredient. After standing in a greenhouse for a week, the plants were inoculated with a spore suspension of rice blast fungus ( Pyricularia oryzae ) by the method of spraying.

After the inoculation, the plants were allowed to stand in a moist chamber for one day and then in a greenhouse for 6 days to cause the disease sufficiently. Then, lesions on each leaf were counted and compared with those in the untreated plot, from which the controlling degree was calculated, whereby the effect was judged according to the following criterion:

The results of the above test demonstrate that the compounds listed in Table 1 were found to have a marked blast-controlling activity. Of these compounds, the following were rated C or higher: Compound Nos. 7, 17-19, 21, 24, 35, 36, 60, 62, 66-69, 77, 83, 84, 87-89, 91, 93-100, 102, 104-106, 109, 129, 150, 162, 180, 209, 220-222, 229, 239, 260, 263, 273, 295, 299, 327, 338, 341, 342, 346, 365, 367, 369, 371 and 376. Especially, the following exhibited so excellent a blast-controlling activity as rated A: Compound Nos. 7, 37, 88, 89, 91, 104, 105, 109, 129, 150, 220, 221, 222, 239, 260, 263, 273, 299, 327, 342, 367 and 371.

›Tables in the description — 7
TABLE 1
NoR 1ABProperty
1H—COPhm.p. 60-61° C.
2HCH 2Cl
3HCH 2OH
4HCH 2OCH 3
5HCH 2OCH 2 Ph
6HCH 2OCH 2 —Q 1
7CH 3—CHOnD 1.5555 (26° C.)
8CH 3—COCH 3
9CH 3—COPhnD 1.6145 (22° C.)
10CH 3—CO(2-Cl—Ph)
11CH 3—CO(4-Cl—Ph)
12CH 3—CO(2-CH 3 —Ph)
13CH 3—CO(4-CH 3 —Ph)
14CH 3—CO(4-i-C 3 H 7 —Ph)
15CH 3—CO(4-CH 3 O—Ph)
16CH 3—CO(4-t-C 4 H 9 —Ph)
17CH 3—CO—(1-CH 3 —Q 2 )m.p. 85-90° C.
18CH 3—CNm.p. 50.4° C.
19CH 3—CH═NOHm.p. 270° C. (dec.)
20CH 3—CH═NOCH 3m.p. 97° C.
21CH 3—CH═NOCH 2 PhnD 1.5998 (25° C.)
22CH 3—CH═NOCH 2 (2-Cl—Ph)
23CH 3—CH═NOCH 2 (3-Cl—Ph)
24CH 3—CH═NOCH 2 (4-Cl—Ph)m.p. 70-80° C.
25CH 3—CH═NOCH 2 (2-CH 3 —Ph)
26CH 3—CH═NOCH 2 (3-CH 3 —Ph)
27CH 3—CH═NOCH 2 (4-CF 3 —Ph)
28CH 3—CH═NOCH 2 (4-OH—Ph)
29CH 3—CH═NOCH 2 (4-CH 3 O—Ph)
30CH 3—CH═NOCH 2 (4-CF 3 O—Ph)
31CH 3—CH═NOCH 2 (4-NH 2 —Ph)
32CH 3—CH═NOCH 2 (4-NO 2 —Ph)
33CH 3—CH═NOCH 2 (4-CN—Ph)
34CH 3—CH═NOCH 2 (4-COOCH 3 —Ph)
35CH 3—CH═NNH 2m.p. 81° C.
36CH 3—CH═NNHCH 3
37CH 3—CH═NNHPhm.p. 218° C.
38CH 3—CH═NNH(2-Cl—Ph)
39CH 3—CH═NNH(2-F-4-Cl—Ph)
40CH 3—CH═NNH(3,5-Cl 2 —Ph)
41CH 3—CH═NNH(3-Cl—Ph)
42CH 3—CH═NNH(3-i-C 3 H 7 O—Ph)
43CH 3—CH═NNH(4-CF 3 —Ph)
44CH 3—CH═NNH(4-Cl—Ph)
45CH 3—CH═NNHCOOCH 3
46CH 3—CH═NNHCOOC 4 H 9 -t
47CH 3—CH═NNHCONHCH 3
48CH 3—CH═NNHCONHC 2 H 5
49CH 3—CH═NNHCON(CH 3 )Ph
50CH 3—CH═NNHCONH(4-Cl—Ph)
51CH 3—CH═NNHCONH(4-t-C 4 H 9 —Ph)
52CH 3—CH═NNHCONH(4-CF 3 —Ph)
53CH 3—CH═NNHCONH(4-i-C 3 H 7 O—Ph)
54CH 3—CH═NNHCONH(4-CF 3 O—Ph)
55CH 3—CH═NNHCSNHCH 3
56CH 3—CH═NNHC(N(CH 3 ) 2 )═NCH 3
57CH 3—CH═NNHC(OCH 3 )═NCH 3
58CH 3—CH═NNHC(SCH 3 )═NCH 3
59CH 3—CH═NNHC(SOCH 3 )═NCH 3
60CH 3—CH═NNH—(4,6-(CH 3 ) 2 —Q 3 )m.p. 182-183° C.
61CH 3—C(Ph)═NOHm.p. 172° C.
62CH 3—C(Ph)═NOCH 3nD 1.5905 (22.8° C.)
63CH 3—C(Ph)═NOC 8 H 17
64CH 3—C(Ph)═NOCH 2 CH═CH 2
65CH 3—C(Ph)═NOCH 2 CCl═CH 2
66CH 3—C(Ph)═NOCH 2 C≡CHnD 1.5945 (22.8° C.)
67CH 3—C(Ph)═NOCH 2 C≡CBr
68CH 3—C(Ph)═NOCH 2 C≡CCl
69CH 3—C(Ph)═NOCH 2 PhnD 1.6183 (23.9° C.)
70CH 3—C(Ph)═NOCH 2 (4-Cl—Ph)
71CH 3—C(Ph)═NOCH 2 (3,4-Cl 2 —Ph)
72CH 3—C(Ph)═NOCH 2 (2,4,6-Cl 3 —Ph)
73CH 3—C(Ph)═NOCH 2 (2-CH 3 —Ph)
74CH 3—C(Ph)═NOCH 2 (3-CH 3 —Ph)
75CH 3—C(Ph)═NOCH 2 (4-CH 3 —Ph)
76CH 3—C(Ph)═NOCH 2 (3-CH 3 O—Ph)
77CH 3—
m.p. 180.1° C.
78CH 3—
m.p. 116.3° C.
79CH 3—C(Ph)═NNH 2m.p. 72.3° C.
80CH 3—C(Ph)═NNHCOOC 2 H 5
81CH 3—C(Ph)═NNHCSNHPh
82CH 3—3-CN—Q 2m.p. 190-200° C.
83CH 3—Q 4
84CH 3—5-CH 3 -5-i-C 3 H 7 -4-(═O)—Q 4m.p. 59° C.
85CH 3—5-(CH 3 ) 2 —Q 5m.p. 114° C.
86CH 3—4-(CH 3 ) 2 -5-(═O)—Q 6m.p. 107° C.
87CH 3—4,6-(CH 3 ) 2 —Q 3m.p. >180° C.
88CH 3—4-CH 3 —Q 7m.p. 89° C.
89CH 3—4-t-C 4 H 9 —Q 7m.p. 61° C.
90CH 3—4-(2-Cl—Ph)—Q 7m.p. 136° C.
91CH 3—4-(4-Cl—Ph)—Q 7m.p. 125° C.
92CH 3—4-(2,4-Cl 2 —Ph)—Q 7m.p. 170° C.
93CH 3—4-(4-CH 3 —Ph)—Q 7m.p. 118° C.
94CH 3—5-CH 3 -4-Ph—Q 7m.p. 151° C.
95CH 3—4-CONHCH 3 —Q 7m.p. 144° C.
96CH 3—4-CH 2 COOH—Q 7m.p. 196° C.
97CH 3—4-CH 2 CONH 2 —Q 7m.p. 182° C.
98CH 3—4-CH 2 COOC 2 H 5 —Q 7m.p. 98° C.
99CH 3—4-CH 2 CONHCH 3 —Q 7m.p. 155° C
100CH 3—4-CH 2 CON(C 2 H 5 ) 2 —Q 7m.p. 132° C.
101CH 3—5-Ph—Q 8m.p. 154° C.
102CH 3—5-SH—Q 8m.p. 182° C.
103CH 3—5-SCH—Q 8m.p. 65° C.
104CH 3CH 2ClnD 1.5590 (26° C.)
105CH 3CH 2OHnD 1.553 (21° C.)
106CH 3CH 2OCH 3nD 1.5180 (26° C.)
107CH 3CH 2OC 4 H 9 -n
108CH 3CH 2OC 8 H 17 -n
109CH 3CH 2OCH 2 PhnD 1.5730 (25° C.)
110CH 3CH 2OCH 2 (2-Cl—Ph)
111CH 3CH 2OCH 2 (3-Cl—Ph)
112CH 3CH 2OCH 2 (4-Cl—Ph)
113CH 3CH 2OCH 2 (2-CH 3 —Ph)
114CH 3CH 2OCH 2 (3-CH 3 —Ph)
115CH 3CH 2OCH 2 (4-t-C 4 H 9 —Ph)
116CH 3CH 2OCH 2 (4-CF 3 —Ph)
117CH 3CH 2OCH 2 (2,4-(CH 3 ) 2 —Ph)
118CH 3CH 2OCH 2 (3,4-(CH 3 ) 2 —Ph)
119CH 3CH 2OCH 2 (4-OH—Ph)
120CH 3CH 2OCH 2 (4-CH 3 O—Ph)
121CH 3CH 2OCH 2 (4-CF 3 O—Ph)
122CH 3CH 2OCH 2 (2,4-(CH 3 O) 2 —Ph)
123CH 3CH 2OCH 2 (3,4-(CH 3 O) 2 —Ph)
124CH 3CH 2OCH 2 (4-NH 2 —Ph)
125CH 3CH 2OCH 2 (4-NO 2 —Ph)
126CH 3CH 2OCH 2 (4-COOCH 3 —Ph)
127CH 3CH 2OCH 2 (4-COOC 4 H 9 -t-Ph)
128CH 3CH 2OCH 2 (4-CN—Ph)
129CH 3CH 2OCH 2 (4-CH 3 —Q 1 )nD 1.547 (26.3° C.)
130CH 3CH 2OPh
131CH 3CH 2O(2-Cl—Ph)
132CH 3CH 2O(3-Cl—Ph)
133CH 3CH 2O(4-Cl—Ph)
134CH 3CH 2O(2-CH 3 —Ph)
135CH 3CH 2O(3-CH 3 —Ph)
136CH 3CH 2O(4-t-C 4 H 9 —Ph)
137CH 3CH 2O(4-CF 3 —Ph)
138CH 3CH 2O(2,4-(CH 3 ) 2 —Ph)
139CH 3CH 2O(3,4-(CH 3 ) 2 —Ph)
140CH 3CH 2O(4-OH—Ph)
141CH 3CH 2O(4-CH 3 O—Ph)
142CH 3CH 2O(4-CF 3 O—Ph)
143CH 3CH 2O(2,4-(CH 3 O) 2 —Ph)
144CH 3CH 2O(3,4-(CH 3 O) 2 —Ph)
145CH 3CH 2O(4-NH 2 —Ph)
146CH 3CH 2O(4-NO 2 —Ph)
147CH 3CH 2O(4-COOCH 3 —Ph)
148CH 3CH 2O(4-COOC 4 H 9 -t-Ph)
149CH 3CH 2O(4-CN—Ph)
150CH 3CH 2O—COCH 3nD 1.3580 (25° C.)
151CH 3CH 2O—COC 2 H 5
152CH 3CH 2O—COC 3 H 7 -n
153CH 3CH 2O—COC 3 H 7 -i
154CH 3CH 2O—COC 4 H 9 -t
155CH 3CH 2O—COC 4 H 9 -s
156CH 3CH 2O—COC 17 H 35 -n
157CH 3CH 2O—COC 6 H 11 -cyclo
158CH 3CH 2O—COCH═CH 2
159CH 3CH 2O—COCH═CHPh
160CH 3CH 2O—COCH 2 Cl
161CH 3CH 2O—COCF 3
162CH 3CH 2O—COPhm.p. 50-53° C.
163CH 3CH 2O—CO(2-Cl—Ph)
164CH 3CH 2O—CO(3-Cl—Ph)
165CH 3CH 2O—CO(4-Cl—Ph)
166CH 3CH 2O—CO(2-CH 3 —Ph)
167CH 3CH 2O—CO(3-CH 3 —Ph)
168CH 3CH 2O—CO(4-t-C 4 H 9 —Ph)
169CH 3CH 2O—CO(4-CF 3 —Ph)
170CH 3CH 2O—CO(2,4-(CH 3 ) 2 —Ph)
171CH 3CH 2O—CO(3.4-(CH 3 ) 2 —Ph)
172CH 3CH 2O—CO(4-CH 3 O—Ph)
173CH 3CH 2O—CO(4-CF 3 O—Ph)
174CH 3CH 2O—CO(2,4-(CH 3 O) 2 —Ph)
175CH 3CH 2O—CO(3,4-(CH 3 O) 2 —Ph)
176CH 3CH 2O—CO(4-NO 2 —Ph)
177CH 3CH 2O—CO(4-COOCH 3 —Ph)
178CH 3CH 2O—CO(4-COOC 4 H 9 -t-Ph)
179CH 3CH 2O—CO(4-CN—Ph)
180CH 3CH 2O—COOC 2 H 5nD 1.5041 (26° C.)
181CH 3CH 2O—COOC 4 H 9 -i
182CH 3CH 2ON═C(CH 3 ) 2
183CH 3CH 2ON═C(CH 3 )C 2 H 5
184CH 3CH 2ON═C 6 H 10 -cyclo
185CH 3CH 2ON═CHPh
186CH 3CH 2ON═CH(2-Cl—Ph)
187CH 3CH 2ON═CH(3-Cl—Ph)
188CH 3CH 2ON═CH(4-Cl—Ph)
189CH 3CH 2ON═CH(2-CH 3 —Ph)
190CH 3CH 2ON═CH(3-CH 3 —Ph)
191CH 3CH 2ON═CH(4-C 4 H 9 -t-Ph)
192CH 3CH 2ON═CH(4-CF 3 —Ph)
193CH 3CH 2ON═CH(2,4-(CH 3 ) 2 —Ph)
194CH 3CH 2ON═CH(3,4-(CH 3 ) 2 —Ph)
195CH 3CH 2ON═CH(4-OH—Ph)
196CH 3CH 2ON═CH(4-CH 3 O—Ph)
197CH 3CH 2ON═CH(4-CF 3 O—Ph)
198CH 3CH 2ON═CH(2,4-(CH 3 O) 2 —Ph)
199CH 3CH 2ON═CH(3,4-(CH 3 O) 2 —Ph)
200CH 3CH 2ON═CH(4-NH 2 —Ph)
201CH 3CH 2ON═CH(4-NO 2 —Ph)
202CH 3CH 2ON═CH(4-COOCH 3 —Ph)
203CH 3CH 2ON═C(CH 3 )Ph
204CH 3CH 2OSO 2 CH 3
205CH 3CH 2OSO 2 CF 3
206CH 3CH 2OSO 2 Ph
207CH 3CH 2OSO 2 (4-Br—Ph)
208CH 3CH 2OSO 2 (4-CH 3 —Ph)Paste
209CH 3CH 2SPhnD 1.636 (24.6° C.)
210CH 3CH 2SOPh
211CH 3CH 2SO 2 Phm.p. 118° C.
212CH 3CH 2SO 2 (4-CH 3 —Ph)
213CH 3CH 2SO 2 (4-NO 2 —Ph)
214CH 3CH 2SCH 2 PhnD 1.612 (24.6° C.)
215CH 3CH 2SO 2 CH 2 Phm.p. 116° C.
216CH 3CH 2SCON(CH 2 CH═CH 2 ) 2
217CH 3CH 2SCO—Q 9
218CH 3CH 2SCOOC 2 H 5
219CH 3CH 2SCSN(C 2 H 5 ) 2
220CH 3CH 2NH 2 .HClm.p. >250° C.
221CH 3CH 2N(C 2 H 5 ) 2Paste
222CH 3CH 2N(CH 2 CH═CH 2 ) 2Paste
223CH 3CH 2NHPh
224CH 3CH 2NH(4-CH 3 —Ph)
225CH 3CH 2NHCOCH 3
226CH 3CH 2NHCOC 2 H 5
227CH 3CH 2NHCOC 3 H 7 -n
228CH 3CH 2NHCOC 3 H 7 -i
229CH 3CH 2NHCOC 4 H 9 -tm.p. 93-94° C.
230CH 3CH 2NHCOC 4 H 9 -s
231CH 3CH 2NHCOC 17 H 35 -n
232CH 3CH 2NHCOC 3 H 5 -cyclom.p. 75-78° C.
233CH 3CH 2NHCO(2,2-Cl 2 —C 3 H 5 -cyclo)
234CH 3CH 2NHCOC 6 H 11 -cyclo
235CH 3CH 2NHCOCH═CH 2
236CH 3CH 2NHCOCH═CHPh
237CH 3CH 2NHCOCH 2 Cl
238CH 3CH 2NHCOCF 3
239CH 3CH 2NHCOPhm.p. 96° C.
240CH 3CH 2NHCO(2-Cl—Ph)
241CH 3CH 2NHCO(3-Cl—Ph)
242CH 3CH 2NHCO(4-Cl—Ph)
243CH 3CH 2NHCO(2-CH 3 —Ph)
244CH 3CH 2NHCO(3-CH 3 —Ph)
245CH 3CH 2NHCO(4-t-C 4 H 9 —Ph)
246CH 3CH 2NHCO(3-CF 3 —Ph)
247CH 3CH 2NHCO(4-CF 3 —Ph)
248CH 3CH 2NHCO(2,4-(CH 3 ) 2 —Ph)
249CH 3CH 2NHCO(3,4-(CH 3 ) 2 —Ph)
250CH 3CH 2NHCO(4-OH—Ph)
251CH 3CH 2NHCO(4-CH 3 O—Ph)
252CH 3CH 2NHCO(4-CF 3 O—Ph)
253CH 3CH 2NHCO(2,4-(CH 3 O) 2 —Ph)
254CH 3CH 2NHCO(3,4-(CH 3 O) 2 —Ph)
255CH 3CH 2NHCO(4-NH 2 —Ph)
256CH 3CH 2NHCO(4-NO 2 —Ph)
257CH 3CH 2NHCO(4-COOCH 3 —Ph)
258CH 3CH 2NHCO(2,4-Cl 2 —Ph)
259CH 3CH 2NHCO(3,4-Cl 2 —Ph)
260CH 3CH 2N(CHO) 2m.p. 70-75° C.
261CH 3CH 2Q 10
262CH 3CH 23,3,4,4,5,5-F 6 —Q 11
263CH 3CH 2Q 12m.p. 124-125° C.
264CH 3CH 2NHCOOCH 3
265CH 3CH 2NHCOOC 2 H 5Paste
266CH 3CH 2NHCOOC 4 H 9 -i
267CH 3CH 2NHCOOC 4 H 9 -t
268CH 3CH 2NHCOO(4-NO 2 —Ph)
269CH 3CH 2NHCOOPh
270CH 3CH 2NHCONHCH 3
271CH 3CH 2NHCONHC 2 H 5
272CH 3CH 2NHCONHC 3 H 7 -i
273CH 3CH 2NHCONHPhm. p. 145° C.
274CH 3CH 2NHCONH(2-Cl—Ph)
275CH 3CH 2NHCONH(3-Cl—Ph)
276CH 3CH 2NHCONH(4-Cl—Ph)
277CH 3CH 2NHCONH(2-CH 3 —Ph)
278CH 3CH 2NHCONH(3-CH 3 —Ph)
279CH 3CH 2NHCONH(4-t-C 4 H 9 —Ph)
280CH 3CH 2NHCONH(3-CF 3 —Ph)
281CH 3CH 2NHCONH(4-CF 3 —Ph)
282CH 3CH 2NHCONH(2,4-(CH 3 ) 2 —Ph)
283CH 3CH 2NHCONH(3,4-(CH 3 ) 2 —Ph)
284CH 3CH 2NHCONH(4-OH—Ph)
285CH 3CH 2NHCONH(3-CH 3 O—Ph)
286CH 3CH 2NHCONH(4-i-C 3 H 7 O—Ph)
287CH 3CH 2NHCONH(4-CF 3 O—Ph)
288CH 3CH 2NHCONH(2,4-(CH 3 O) 2 —Ph)
289CH 3CH 2NHCONH(3,4-(CH 3 O) 2 —Ph)
290CH 3CH 2NHCONH(4-NH 2 —Ph)
291CH 3CH 2NHCONH(4-NO 2 —Ph)
292CH 3CH 2NHCONH(4-COOCH 3 —Ph)
293CH 3CH 2NHCONH(2,4-Cl 2 —Ph)
294CH 3CH 2NHCSNHCH 3
295CH 3CH 2NHCSNHPhm.p. 171-172° C.
296CH 3CH 2NHC(═NCH 3 )OC 2 H 5
297CH 3CH 2NHC(═NPh)N(C 2 H 5 ) 2
298CH 3CH 2NHC(═NPh)SCH 3
299CH 3CH 2NHSO 2 (4-CH 3 —Ph)Paste
300CH 3CH 2NHNH 2
301CH 3CH 2NHN═C(CH 3 ) 2
302CH 3CH 2NHN═CHPh
303CH 3CH 2NHN═C(CH 3 )Ph
304CH 3CH 2Q 13
305CH 3CH 2Q 14
306CH 3CH 2Q 15
307CH 3CH 2CHO
308CH 3CH 2CN
309CH 3CH 2COOCH 3
310CH 3CH 2COOC 2 H 5
311CH 3CH 2COOC 3 H 7 -i
312CH 3CH 2COOC 8 H 17 -n
313CH 3CH 2COOCH 2 CH═CH 2
314CH 3CH 2CONH 2
315CH 3CH 2CONHCH 3
316CH 3CH 2CONHC 3 H 7 -i
317CH 3CH 2CON(CH 3 ) 2
318CH 3CH 2CO—Q 16
319CH 3CH 2CO—Q 17
320CH 3CH 2CO—Q 18
321CH 3CH 2CO—Q 19
322CH 3CH 2CH(COCH 3 ) 2
323CH 3CH 2CH(COOC 2 H 5 ) 2
324CH 3CH 2C(NHCOCH 3 )(COOC 2 H 5 ) 2m.p. 93-97° C.
325CH 3CH 2CH(SCH 3 )(SOCH 3 )
326CH 3CH 2Q 20
327CH 3CHClCOOCH 3nD 1.5456 (23° C.)
328CH 3CHCH 3CN
329CH 3CHCH 3COOCH 3
330CH 3C(CH 3 ) 2CN
331CH 3C(CH 3 ) 2COOCH 3
332CH 3CHPhClnD 1.5979 (21.8° C.)
333CH 3CHPhOHm.p. 93.2° C.
334CH 3CHPhOCH 3
335CH 3CHPhCN
336CH 3CHPhCOOH
337CH 3CH 2 CH 2COOCH 3
338CH 3CH═CH (E)COOCH 3m.p. 70° C.
339CH 3CH═CH (E)CON(CH 3 ) 2
340CH 3CH═CH (E)CONHPh
341CH 3CH═CH (Z)COOCH 3m.p. 80-85° C.
342CH 3CH═CHCHOm.p. 77-78° C.
(E, Z mixture)
343CH 3C═C(SCH 3 ) 2CN
344CH 3Q 21CN
345CH 3C═C(COOCH 3 ) 2H
346CH 3C═C(COOCH 3 )CNHPaste
347CH 3Q 22CN
348C 2 H 5CH 2Cl
349C 2 H 5CH 2OH
350C 2 H 5CH 2OCH 3
351C 2 H 5CH 2OCH 2 Ph
352C 2 H 5CH 2OCH 2 (4-C 2 H 5 —Q 1 )
353C 3 H 7 -iCH 2F
354C 3 H 7 -iCH 2Cl
355C 3 H 7 -iCH 2Br
356C 3 H 7 -iCH 2I
357C 3 H 7 -iCH 2OH
358C 3 H 7 -iCH 2OCH 3
359C 3 H 7 -iCH 2OCH 2 Ph
360C 3 H 7 -iCH 2OCH 2 (4-i-C 3 H 7 —Q 1 )
361C 3 H 7 -iCH 2NH 2 .HCl
362C 3 H 7 -iCH 2N(CH 3 ) 2
363C 3 H 7 -iCH 2N(CH 2 CH═CH 2 ) 2
364C 3 H 7 -iCH 2NHCOCH 3
365CH 2 ClCH 2OHPaste
366CF 3CH 2OH
367Ph—Q 4m.p. 150° C.
368Ph—Q 5m.p. 158° C.
369Ph—5-(CH 3 ) 2 —Q 5m.p. 147° C.
370Ph—4-CH 3 —Q 7m.p. 161° C.
371Ph—4-t-C 4 H 9 —Q 7m.p. 110° C.
372Ph—4-COOCH 3 —Q 7m.p. 124° C.
373Ph—4-CONHCH 3 —Q 7m.p. 187° C.
374Ph—4-CH 2 COOH—Q 7m.p. 137° C.
375Ph—4-CH 2 CONH 2 —Q 7m.p. 137° C.
376Ph—4-CH 2 CONHCH 3 —Q 7m.p. 154° C.
377Ph—5-CH 3 —Q 23m.p. 85° C.
378PhCH 2Cl
379PhCH 2OH
380PhCH 2OCH 3
381PhCH 2OCH 2 Ph
382PhCH 2OCH 2 (4-Ph—Q 1 )
383PhCH 2COOCH 3
384PhCH 2CON(CH 3 )Ph
385PhCH 2CONH(4-CH 3 O—Ph)m.p. 129° C.
3862-Cl—PhCH 2OH
3873-Cl—PhCH 2OH
3884-Cl—PhCH 2OH
3894-CH 3 —PhCH 2OH
3903-CH 3 —PhCH 2OH
3914-CH 3 —PhCH 2OH
3924-t-C 4 H 9 —PhCH 2OH
3932-CF 3 —PhCH 2OH
3944-CF 3 —PhCH 2OH
3952,4-(CH 3 ) 2 —PhCH 2OH
3963,4-(CH 3 ) 2 —PhCH 2OH
3974-OH—PhCH 2OH
3984-CH 3 O—PhCH 2OH
3994-CF 3 O—PhCH 2OH
4004-PhO—PhCH 2OH
4012,4-(CH 3 O) 2 —PhCH 2OH
4023,4-(CH 3 O) 2 —PhCH 2OH
4034-COOCH 3 —PhCH 2OH
4042,4-Cl 2 —PhCH 2OH
4053,4-Cl 2 —PhCH 2OH
406Q 24CH 2OH
407Q 25CH 2OH
408Q 26CH 2OH
409Q 27CH 2OHm.p. 158° C.
410Q 28CH 2OH
4116-Cl—Q 27CH 2OH
412Q 27—CNm.p. 129° C.
4134-F—PhCH 2O—CO—(4-Cl—Ph)m.p. 79° C.
4144-F—PhCH 2O—(4-CH 3 O—Ph)m.p. 86° C.
4154-F—PhCH 2O—CO—CH 2 —(4-CH 3 —Ph)m.p. 113° C.
4164-F—PhCH 2O—CO—NH—Phm.p. 99° C.
4174-F—PhCH 2ON═C(CH 3 )(4-Cl—Ph)m.p. 91° C.
4184-F—PhCH 2OHm.p. 100° C.
4194-F—PhCH 2Brm.p. 88° C.
4204-F—PhCH 2O—CO—CH 3m.p. 59° C.
421Q 26—CNm.p. 190° C.
422PhCH 2CONH—(4-CH 3 O—Ph)m.p. 129° C.
423Ph—C═NOH(NH 2)m.p. 130° C.
424Ph—CN
425CH 3—Q 8Paste
426CH 3—5-CH 3 —Q 8nD 1.5661 (26.4° C.)
427CH 3—SCH 2 CH═CH 2Paste
428CH 3—SCH 2 C≡CHPaste
429CH 3—SCH 2 —Phm.p. 89° C.
430CH 3—SCH 2 —(4-t-C 4 H 9 —Ph)m.p. 79° C.
431CH 3—S—C 3 H 7 -iPaste
432CH 3—S—CH 2 —Q 27m.p. 78° C.
433CH 3—S—CH 2 —Q 28m.p. 97° C.
TABLE 2
NoH-NMR[CDCl 3 /TMS, δ value (ppm)]
2082.46(s, 3H), 2.63(s, 3H), 5.35(s, 2H), 7.35(d, 2H),
7.77(d, 2H).
2211.05(t, 6H), 2.54(q, 4H), 2.63(s, 3H), 3.78(s, 2H).
2222.61(s, 3H), 3.10-3.12(m, 4H), 3.80(s, 2H),
5.16-5.24(m, 4H), 5.78-5.89(m, 2H).
2651.25(t, 3H), 2.63(s, 3H), 4.15(q, 2H), 4.59(d, 2H),
5.2-5.35(br, 1H).
2992.44(s, 3H), 2.58(s, 3H), 4.42(d, 2H), 5.37(br, t, 1H),
7.31(d, 2H), 7.70(d, 2H).
3461.41(t, 3H), 2.90(s, 3H), 4.20(q, 2H), 8.34(s, 1H).
3652.58(t, 1H), 5.03(s, 2H), 5.16(d, 2H).
4263.08(s, 3H), 3.96(d, 2H), 5.27(d, 1H), 5.43(d, 1H),
6.00(m, 1H).
4273.08(s, 3H), 5.23(d, 2H), 6.28(s, 1H).
4301.55(d, 6H), 3.08(s, 3H), 4.02(m, 1H).
The compound shown in Table 150parts
Xylene40parts
Mixture of polyoxyethylene nonyl-10parts
phenyl ether and calcium alkyl-
benzenesulfonate
The compound shown in Table 13parts
Clay powder82parts
Diatomaceous earth powder15parts
The compound shown in Table 15parts
Powdery mixture of bentonite and90parts
clay
Calcium ligninsulfonate5parts
The compound shown in Table 120parts
Kaolinite and synthetic high-75parts
dispersion silicic acid
Mixture of polyoxyethylene5parts
nonylphenyl ether and calcium
alkylbenzenesulfonate
EffectControlling degree (%)
A100-95
B94-85
C84-60
D59-0
1 of 29 part labels are ours — the grant heads the rest

Claims as granted

6 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

13 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N47/32
  • A01N53/00
  • A01N43/82
  • A01N47/30
  • A01N47/18
  • A01N47/20
  • A01N47/12
  • A01N47/06
Section C — Chemistry; metallurgy
  • C07D417/04
  • C07D417/12
  • C07D285/06
USPC · US Patent Classification
514/361548/127

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomOct 2000Jan 2001Apr 2001Jul 2001Oct 2001Jan 2002USPTOApplicantNon-final rejectionResponse after non-finalNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.3 y
476 days filing → grant
Office actions
1
non-final + final
Responses
2
no RCE
Examiner
Robert Gerstl
art unit 1626 · TC 1600
Citations: 31 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom20002002200420062008201020122014201620182020Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock